Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

312
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

2.8K
2.8K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.5K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.9K
5.9K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

419
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
419

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of fathers and male role models on recovery and resilience in pediatric victims of violent trauma.

The journal of trauma and acute care surgery·2026
Same author

The power of parts and the strength of the whole: Aggregation, disaggregation, and a strategic vision for the society of Asian academic surgeons.

American journal of surgery·2026
Same author

Implementation and Effectiveness of an Enhanced Recovery Protocol for Children Undergoing Surgery: The ENRICH-US Stepped-Wedge Cluster-Randomized Trial.

JAMA surgery·2026
Same author

Non-Wilms Renal Tumours in Children: The Republic of Ireland Experience.

Children (Basel, Switzerland)·2026
Same author

Outcomes of pediatric blunt liver and spleen injury in 1029 patients using the ATOMAC+ pediatric trauma research network guideline.

Journal of pediatric surgery·2026
Same author

International Society of Paediatric Surgical Oncology (IPSO) Minimally Invasive Surgery (MIS) Guidelines.

Ecancermedicalscience·2026
Same journal

Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026
Same journal

Beyond the Scalpel's Reach.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Society.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Hospitals.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions for Providers.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Patients Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026
See all related articles

Related Experiment Video

Updated: Mar 16, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.7K

Pediatric Sarcomas.

Regan F Williams1, Israel Fernandez-Pineda2, Ankush Gosain1

  • 1Department of Surgery, University of Tennessee Health Science Center, 49 North Dunlap Avenue, Second Floor, Memphis, TN 38105, USA.

The Surgical Clinics of North America
|August 21, 2016
PubMed
Summary
This summary is machine-generated.

Pediatric sarcomas, a group of childhood solid tumors, are treated with multimodal therapy. Current approaches aim to reduce side effects in low-risk cases and improve survival in metastatic disease.

Keywords:
Ewing’s sarcomaNonrhabdomyosarcoma soft tissue sarcomaOsteosarcomaRhabdomyosarcoma

More Related Videos

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

7.7K
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

11.9K

Related Experiment Videos

Last Updated: Mar 16, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.7K
Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

7.7K
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

11.9K

Area of Science:

  • Pediatric Oncology
  • Cancer Research
  • Tumor Biology

Background:

  • Pediatric sarcomas represent approximately 10% of childhood solid tumors.
  • Multimodality therapy has significantly improved prognosis over the last two decades.
  • Treatment strategies are evolving to balance efficacy and long-term side effects.

Purpose of the Study:

  • To provide an overview of pediatric sarcoma treatment strategies.
  • To highlight the importance of risk stratification in treatment planning.
  • To discuss the classification and common types of pediatric sarcomas.

Main Methods:

  • Review of current treatment paradigms for pediatric sarcomas.
  • Classification of pediatric sarcomas into soft tissue and osseous types.
  • Identification of common subtypes including rhabdomyosarcomas, nonrhabdomyosarcomas, osteosarcomas, and Ewing's sarcoma.

Main Results:

  • Treatment focuses on decreasing therapy for low-risk patients to minimize long-term side effects.
  • Maximal therapy is employed for patients with metastatic disease to enhance survival rates.
  • Pediatric sarcomas are broadly categorized into soft tissue and bone tumors.

Conclusions:

  • Risk-adapted therapy is crucial for optimizing outcomes in pediatric sarcoma patients.
  • Understanding sarcoma subtypes is essential for targeted treatment approaches.
  • Continued research aims to refine treatment protocols for improved survival and reduced toxicity.